DESOGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL
DESOGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: DESOGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL; Generic name: DESOGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL; Manufacturer: Mylan Pharmaceuticals Inc..
| Brand name | DESOGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL |
|---|---|
| Generic name | DESOGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL |
| Manufacturer | Mylan Pharmaceuticals Inc. |
| Used for | INDICATIONS AND USAGE Desogestrel and ethinyl estradiol tablets and ethinyl estradiol tablets are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. Oral contraceptives are highly effective. Table II lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. The efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. Correct and consistent use of these methods can result in lower failure rates. TABLE II: PERCENTAGE OF WOMEN EXPERIENCING AN UNINTENDED PREGNANCY DURING THE FIRST YEAR OF TYPICAL USE AND THE F |
| Dosage | DOSAGE AND ADMINISTRATION To achieve maximum contraceptive effectiveness, maximum contraceptive effectiveness, desogestrel and ethinyl estradiol tablets and ethinyl estradiol tablets must be taken exactly as directed and at intervals not exceeding 24 hours. Desogestrel and ethinyl estradiol tablets and ethinyl estradiol tablets may be initiated using either a Sunday start or a Day 1 start. NOTE: Each blister is preprinted with the days of the week, starting with Sunday, to facilitate a Sunday st |
| Warnings | WARNINGS The use of oral contraceptives is associated with increased risks of several serious conditions including myocardial infarction, thromboembolism, stroke, hepatic neoplasia, and gallbladder disease, although the risk of serious morbidity or mortality is very small in healthy women without underlying risk factors. The risk of morbidity and mortality increases significantly in the presence of other underlying risk factors such as hypertension, hyperlipidemias, obesity, and diabetes. Practi |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=142c4b90-c9ab-45ce-9172-f1ea7d366686 |